Hulio
Product Images NDC 83257-017
Product Visual Gallery
This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Hulio (NDC 83257-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biocon Biologics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-29 (Image 29)
Image-30 (Image 30)
Image-32 (Image 32)
Injection Diary (Image 33)
Figure B (Image 05)
Figure C (Image 06)
Figure D (Image 07)
Figure E (Image 08)
Figure F (Image 09)
Figure G (Image 10)
Figure H (Image 11)
Figure I (Image 12)
Figure J (Image 13)
Figure 3 : Kaplan-meier Curves Summarizing Time To Treatment Failure On Or After Week 6 (study Uv I) Or Week 2 (study Uv Ii) (Image 027)
Figure-a (Image 04)
Figure B (Image 017)
Figure C (Image 018)
Figure D (Image 016)
Figure J (Image 034)
Figure 1. Study Ra-iii Acr 20 Responses Over 52 Weeks (Image 01)
Figure 2. Asas 20 Response By Visit, Study As-i (Image 02)
Instructions For Use Figure A (Image 15)
Instructions For Use Figure E (Image 19)
Instructions For Use Figure F (Image 20)
Instructions For Use Figure G (Image 21)
Instructions For Use Figure H (Image 22)
Instructions For Use Figure I (Image 23)
Hulio Prefilled Syringe Carton (20 mg/0.4 mL)
Hulio Prefilled Syringe Carton (40 mg/0.8 mL)
Hulio Prefilled Pen (40 mg/0.8 mL)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.